Methods for monitoring drug activities in vivo
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 5, 2010
Grant Date -
Nov 25, 2004
app pub date -
Mar 5, 2004
filing date -
Feb 11, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulatable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully